Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
In vivo kinetic studies using stable isotopes and mathematical modeling demonstrate that impaired clearance of VLDL1-triglycerides is a primary driver of hypertriglyceridemia in abdominal obesity.
To develop novel strategies for prevention and treatment of dyslipidemia, it is essential to understand the pathophysiology of dyslipoproteinemia in humans. Lipoprotein metabolism is a complex system in which abnormal concentrations of various lipoprotein particles can result from alterations in their rates of production, conversion, and/or catabolism. Traditional methods that measure plasma lipoprotein concentrations only provide static estimates of lipoprotein metabolism and hence limited mechanistic information. By contrast, the use of tracers labeled with stable isotopes and mathematical modeling, provides us with a powerful tool for probing lipid and lipoprotein kinetics in vivo and furthering our understanding of the pathogenesis of dyslipoproteinemia.
No takes yet. Share an insight, caveat, or question.
Adiels et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: